MedPath

Perifollicular Doppler in Natural Cycle In Vitro Fertilization

Completed
Conditions
Infertility
Interventions
Procedure: Doppler ultrasound
Registration Number
NCT01668212
Lead Sponsor
Clinique Ovo
Brief Summary

Perifollicular Doppler could reflect the quality of the follicle's vascularization and, consequently, the one of the oocyte that ensues from it. Perifollicuar Doppler is the analysis, in ultrasound, of the blood flow in vessels surrounding the follicle.

The goal of this study is to evaluate if there is a link, in natural cycle In Vitro Fertilization, between the quality of the vascularization and the one of the oocyte, the embryo and the pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Patient with a natural In Vitro Fertilization cycle.
  • Patient under 38 years old
  • Body mass indice under 35
  • Ovulatory cycles between 20-35 days
Exclusion Criteria
  • Patient with a stimulation In Vitro Fertilization cycle
  • Patient with a naturalIn Vitro Fertilization cycle with egg donor
  • Patient with a natural In Vitro Fertilization cycle with freezing embryo
  • Smoking patient
  • Diabetic patient
  • Patient with treatment of antihypertensive drug, anticoagulant, antiplatelet, vasodilator
  • Body mass indice over 35
  • Patient over 38 years old
  • Patient without ovulation or cycle over 35 days
  • Percutaneous Epididymal Sperm Aspiration (PESA), Testicular Sperm Extraction (TESE) or micro TESE

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
natural In Vitro Fertilization cycleDoppler ultrasoundPatient doing following natural In Vitro fertilization cycle
Primary Outcome Measures
NameTimeMethod
Quality perifollicular doppler and quality of the oocyte2 weeks

The measurements are done twice; on days of induction and oocyte retrieval. During the blood sample collection on the day of the induction, there is also a measurement of progesterone, estradiol and luteinizing hormone (LH).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ovo Fertilité

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath